Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery

Oct.12.2024
Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
A new Innokin Trine e-cigarette with replaceable battery has hit shelves in Europe, meeting upcoming EU regulations.

Recently, 2Firsts noticed a new type of replaceable battery e-cigarette called the Innokin Trine being showcased at a tobacco exhibition in Dortmund. The product, launched by e-cigarette brand Innokin, is now available on e-cigarette retail websites in regions such as the UK and Germany. With its design allowing for replaceable batteries, the product complies with the new regulations set to be implemented by the EU Battery Directive in 2026.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Innokin Trine displayed at the tobacco exhibition in Dortmund by Innokin|Image source: 2Firsts


At the recent Dortmund tobacco exhibition, several exhibitors showcased e-cigarette products with replaceable batteries, including disposable, pod-based, and open-system devices, in response to the EU's Battery Directive. According to the directive, by 2026, batteries in portable devices (such as disposable e-cigarettes) must be easily removable and replaceable by the user.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image Source | Innokin Official Website


The newly released Innokin Trine, an open system product from Innokin, complies with the upcoming new regulations in the European Union market.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image source | Innokin official website


In addition, the main feature of Trine is its "three-in-one" structure: atomizer, detachable and rechargeable battery, control panel. At the same time, the detachable and rechargeable battery enhances the convenience and durability of the device.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image source | Innokin brand official website


Specifically, the main product features of the Innokin Trine include:


E-liquid capacity: 2ml Nicotine concentration: Supports a variety of nicotine levels in e-liquid Battery capacity: 1000mAh removable battery Charging method: Supports Type-C fast charging.


Trine Power Hub charger charges


Backup batteries can also be purchased separately.


Power Mode: Provides a power output of 6-25W.


Function: - Suction activation


Support mouth to lung (MTL) or limit direct lung (RDL) inhale mode.


Compatible with a variety of e-liquid flavors.


Charging indicator light


The screen displays operational parameters such as output power and battery level.


Currently, the Innokin Trine has been listed on the official website of the Innokin e-cigarette brand and major distributor websites in Europe, with a selling price of approximately 19.95 euros.


In addition to the Innokin brand, other brands such as GOLISI and NEXIONE have also introduced similar products with replaceable batteries. 2Firsts will continue to monitor the latest products and market trends in replaceable battery e-cigarette products, providing the public with accurate and authoritative industry information.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Thailand's E-Cigarette Ban Supported by WHO, Government Launches "De-Normalization" Campaign to Tackle Youth E-Cigarette Use
Thailand's E-Cigarette Ban Supported by WHO, Government Launches "De-Normalization" Campaign to Tackle Youth E-Cigarette Use
The WHO supports Thailand’s ongoing e-cigarette import and sales ban, citing harm evidence and the Tobacco Control Framework. ThaiHealth has launched a "de-normalization" campaign to reduce youth e-cigarette use. Surveys show 25% of Thai students have tried e-cigarettes, with usage linked to social environments. E-cigarette companies' commercial and political influence challenges tobacco control efforts.
Aug.06 by 2FIRSTS.ai
Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
2Firsts received a legal commentary from lawyer Zheng Mingwei’s team, analyzing the FDA’s approval of JUUL menthol e-cigarettes. The article outlines key scientific data, regulatory standards, and industry implications.
Jul.22
2Firsts Interview | Sneak Peek: Westfallenhallen’s Sabine Loos Reveals What Visitors Can Expect at InterTabac 2025
2Firsts Interview | Sneak Peek: Westfallenhallen’s Sabine Loos Reveals What Visitors Can Expect at InterTabac 2025
As an official media partner of InterTabac, 2Firsts spoke exclusively with Sabine Loos, Managing Director of Westfalenhallen Unternehmensgruppe, to preview the 45th edition of the event. This year’s InterTabac and InterSupply will feature 11 halls, over 800 exhibitors, dozens of forums, and major product debuts. The interview explores trends in NGPs, oral nicotine, hybrid formats, and global regulatory topics—offering a comprehensive look into innovation and industry dialogue.
Aug.06
SKE Launches New CL2000 Refillable Pod Vape in the UK with 1.8mL + 2.2mL Dual-Pod Design
SKE Launches New CL2000 Refillable Pod Vape in the UK with 1.8mL + 2.2mL Dual-Pod Design
The SKE CL2000 e-cigarette features a dual-pod setup combining 1.8mL and 2.2mL capacities, delivering a total of 2,000 puffs. The brand claims it is equipped with a “plug-and-play pod system with auto-refill technology.” The product has been listed with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and will soon be available through UK distributors at a retail price of around £10.99.
Aug.14 by 2FIRSTS.ai
U.S. Senate Panel Approves $200 Million for FDA to Crack Down on Illegal E-Cigarettes and Nicotine Pouches, and Urges Faster Product Reviews
U.S. Senate Panel Approves $200 Million for FDA to Crack Down on Illegal E-Cigarettes and Nicotine Pouches, and Urges Faster Product Reviews
The U.S. Senate Appropriations Committee approved $200 million for the FDA to crack down on illegal e-cigarettes and nicotine pouches and urged faster premarket product reviews. The bill now moves to the full Senate and still requires further approval and presidential signing.
Jul.15
2Firsts Interviews Harm Reduction Policy Expert Jeannie Cameron: WHO’s Rejection of Harm Reduction Is Undermining Global Tobacco Control
2Firsts Interviews Harm Reduction Policy Expert Jeannie Cameron: WHO’s Rejection of Harm Reduction Is Undermining Global Tobacco Control
As part of its GFN media partnership, 2Firsts spoke with FCTC expert Jeannie Cameron, who warns that the WHO’s rejection of harm reduction is leading global tobacco control efforts off course.
Jun.18